GlassScriptPhysician profile
Tarek Ahdab
NPI 1184849747
$4,990.31
in general payments reported to CMS, 2019-2025
23 companies · $46.51 in 2025
The $46.51 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,744 · 2020: $478 · 2021: $382 · 2022: $298 · 2023: $572 · 2024: $1,470 · 2025: $46.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065 · Travel and Lodging: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.85 |
| Travel and Lodging | $1,023.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,734.17 | 2021-2024 | Rotarexs 6 F X 135 Cm, Crosser Iq, Lutonix Drug Coated Balloon |
| Avinger INC. | $855.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $604.11 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $286.72 | 2019-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $261.63 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $192.40 | 2019-2023 | Lifevest |
| Boston Scientific Corporation | $181.79 | 2019-2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Varithena Administration Pack |
| Amgen INC. | $151.67 | 2019-2024 | Repatha |
| Pfizer INC. | $114.01 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $103.30 | 2019-2020 | |
| Medtronic, INC. | $91.25 | 2021-2024 | Venaseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.70 | 2019-2020 | |
| Amarin Pharma, INC. | $61.44 | 2019-2020 | |
| Esperion Therapeutics, INC. | $55.72 | 2022-2023 | Nexletol |
| Medtronic Vascular, INC. | $44.27 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $31.63 | 2019-2020 | |
| Edwards Lifesciences Corporation | $23.35 | 2020 | |
| Portola Pharmaceuticals, LLC | $22.94 | 2019 | |
| Lantheus Medical Imaging, INC. | $21.20 | 2022 | |
| Abbott Laboratories | $18.37 | 2022 | |
| Angiodynamics, INC. | $16.53 | 2020 | |
| Tactile Systems Technology INC | $14.45 | 2023 | Entre Plus, Flexitouch Plus |
| Kiniksa Pharmaceuticals International, Plc | $13.94 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Ahdab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.